Menu
GWAS Study

A genome-wide association study of prognosis in breast cancer.

Azzato EM, Pharoah PD, Harrington P et al.

20332263 PubMed ID
GWAS Study Type
5480 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

AE
Azzato EM
PP
Pharoah PD
HP
Harrington P
ED
Easton DF
GD
Greenberg D
CN
Caporaso NE
CS
Chanock SJ
HR
Hoover RN
TG
Thomas G
HD
Hunter DJ
KP
Kraft P
Chapter II

Abstract

Summary of the research findings

Traditional clinicopathologic features of breast cancer do not account for all the variation in survival. Germline genetic variation may provide additional prognostic information.

1,145 female individuals

Chapter III

Study Statistics

Key metrics and study information

5480
Total Participants
GWAS
Study Type
Yes
Replicated
4,335 European ancestry female individuals
Replication Participants
European
Ancestry
U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.